News
CHMP recommends drug for WM
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) is recommending that ibrutinib (Imbruvica) be approved to...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) is recommending that ibrutinib (Imbruvica) be approved to...
Dr. Andrew A. Nierenberg explores cutting-edge treatments for patients with mood disorders.
Photo by Sam Ogden A chemical strategy may allow researchers to target “undruggable” proteins and overcome resistance to current targeted...
PARIS—New research suggests that patients who have undergone primary percutaneous coronary intervention (PCI) have a low risk of stent thrombosis...
Photo by Graham Colm A new method for identifying immune cells could pave the way for rapid detection of hematologic malignancies from a small...
Co-infection with malaria and a virus closely related to the Epstein-Barr virus (EBV) may make the malaria lethal, according to preclinical...
DXA is underused in women who meet the U.S. Preventive Services Task Force criteria for osteoporosis screening and overused in women who do not....